Literature DB >> 25359495

New structural insights into the apelin receptor: identification of key residues for apelin binding.

Romain Gerbier1, Vincent Leroux1, Pierre Couvineau1, Rodrigo Alvear-Perez1, Bernard Maigret1, Catherine Llorens-Cortes2, Xavier Iturrioz2.   

Abstract

Apelin is the endogenous ligand of the orphan 7-transmembrane domain GPCR APJ, now named the apelin receptor (ApelinR). Apelin plays a prominent role in body fluid and cardiovascular homeostasis. To better understand the structural organization of the ApelinR, we built 3 homology 3-dimensional (3D) models of the human ApelinR using the validated cholecystokinin receptor-1 3D model or the X-ray structures of the β2-adrenergic and CXCR4 receptors as templates. Docking of the pyroglutamyl form of apelin 13 (pE13F) into these models revealed the conservation at the bottom of the binding site of a hydrophobic cavity in which the C-terminal Phe of pE13F was embedded. In contrast, at the top of the binding site, depending on the model, different interactions were visualized between acidic residues of the ApelinR and the basic residues of pE13F. Using site-directed mutagenesis, we showed that Asp 92, Glu 172, and Asp 282 of rat ApelinR are key residues in apelin binding by interacting with Lys 8, Arg 2, and Arg 4 of pE13F, respectively. These residues are only seen in the CXCR4-based ApelinR 3D model, further validating this model. These findings bring new insights into the structural organization of the ApelinR and the mode of apelin binding. © FASEB.

Entities:  

Keywords:  APJ; G protein–coupled receptor; homology models; molecular modeling; site-directed mutagenesis

Mesh:

Substances:

Year:  2014        PMID: 25359495     DOI: 10.1096/fj.14-256339

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

Review 3.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

4.  Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands.

Authors:  Kyungsoo Shin; Nigel A Chapman; Muzaddid Sarker; Calem Kenward; Shuya K Huang; Nathan Weatherbee-Martin; Aditya Pandey; Denis J Dupré; Jan K Rainey
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-05-22       Impact factor: 3.770

Review 5.  Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.

Authors:  Peiran Yang; Janet J Maguire; Anthony P Davenport
Journal:  Trends Pharmacol Sci       Date:  2015-07-01       Impact factor: 14.819

Review 6.  Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders.

Authors:  Adrien Flahault; Pierre Couvineau; Rodrigo Alvear-Perez; Xavier Iturrioz; Catherine Llorens-Cortes
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

7.  [Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13.

Authors:  Peiran Yang; Rhoda E Kuc; Aimée L Brame; Alex Dyson; Mervyn Singer; Robert C Glen; Joseph Cheriyan; Ian B Wilkinson; Anthony P Davenport; Janet J Maguire
Journal:  Front Neurosci       Date:  2017-02-28       Impact factor: 4.677

Review 8.  Apelin in Reproductive Physiology and Pathology of Different Species: A Critical Review.

Authors:  Patrycja Kurowska; Alix Barbe; Marta Różycka; Justyna Chmielińska; Joelle Dupont; Agnieszka Rak
Journal:  Int J Endocrinol       Date:  2018-06-06       Impact factor: 3.257

Review 9.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 10.  The therapeutic potential of apelin in kidney disease.

Authors:  Fiona A Chapman; Duuamene Nyimanu; Janet J Maguire; Anthony P Davenport; David E Newby; Neeraj Dhaun
Journal:  Nat Rev Nephrol       Date:  2021-08-13       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.